ArticleJournal of multidisciplinary healthcare2025
Practice of High-Flow Nasal Cannula in Patients with Mild to Moderate COPD Among Healthcare Providers in Saudi Arabia: A Cross-Sectional Study.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High-flow nasal cannula (HFNC) has emerged as a promising non-invasive oxygen therapy for patients with chronic obstructive pulmonary disease (COPD), particularly those with mild to moderate hypercapnia. Despite its growing use, no studies in Saudi Arabia have explored healthcare providers' clinical practices or perceived barriers related to HFNC application in this patient population. This study aimed to assess the current clinical use and implementation challenges of HFNC among physicians and respiratory therapists (RTs) in Saudi Arabia. Methods: A cross-sectional survey was conducted among physicians and RTs across Saudi Arabia from October 27, 2024, to May 20, 2025. The survey, distributed via several channels, collected data on HFNC practices, initial settings, weaning approaches, and perceived barriers. Descriptive statistics presented as frequencies and percentages. Chi-square tests were used to assess differences between physicians and RTs, with a significance level set at p < 0.05. Results: A total of 1724 healthcare providers completed the survey, including 636 (36.9%) physicians and 1,088 (63.1%) RTs. Significant variations were found between the two groups regarding who initiates HFNC, preferred flow rates, and temperature settings (p < 0.05). The most common flow rate selected was 30-40 L/min (47.2%), and initial FiO Conclusion: There is an inconsistent clinical practice regarding HFNC use in mild to moderate COPD among healthcare providers in Saudi Arabia. Addressing knowledge gaps and standardizing protocols may enhance the effective implementation of HFNC therapy and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.